Abemaciclib for malignant pleural mesothelioma.

Lancet Oncol

Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA; Italian Group for Research and Therapy for Mesothelioma, Voghera, Italy. Electronic address:

Published: June 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(22)00276-5DOI Listing

Publication Analysis

Top Keywords

abemaciclib malignant
4
malignant pleural
4
pleural mesothelioma
4
abemaciclib
1
pleural
1
mesothelioma
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!